Diagnostics firms should still get fair valuation in IPOs: Thyrocare’s Velumani 
Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have fallen...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
- Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
- Daily, weekly and monthly curated newsletters on the deal ecosystem in India
- Breaking news alerts
- Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced
Leave Your Comment(s)
